Repro Med Systems/$KRMD
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About Repro Med Systems
KORU Medical Systems Inc is a developer and manufacturer of medical devices and supplies. It focuses on mechanical infusion products, the FREEDOM Infusion Systems. Its primary products include the Freedom Integrated Infusion System: the FREEDOM60 and FreedomEdge Syringe Drivers, Precision Flow Rate Tubing, HIgH-Flo Subcutaneous Safety Needle Sets and Precision Flow Rate Tubing. It is a manufacturer of subcutaneous infusion devices that deliver life-saving immunoglobulin therapies to patients with chronic illnesses such as Primary Immunodeficiencies (PIDD) and Chronic Inflammatory Demyelinating Polyneuropathy (CIDP).
Ticker
$KRMD
Sector
Primary listing
Employees
80
Headquarters
Website
KRMD Metrics
BasicAdvanced
$203M
-
-$0.10
0.47
-
Price and volume
Market cap
$203M
Beta
0.47
52-week high
$5.05
52-week low
$1.86
Average daily volume
137K
Financial strength
Current ratio
2.905
Quick ratio
2.172
Long term debt to equity
17.785
Total debt to equity
20.977
Profitability
EBITDA (TTM)
-4.1
Gross margin (TTM)
63.15%
Net profit margin (TTM)
-12.25%
Operating margin (TTM)
-13.16%
Effective tax rate (TTM)
-0.45%
Revenue per employee (TTM)
$460,000
Management effectiveness
Return on assets (TTM)
-11.48%
Return on equity (TTM)
-25.63%
Valuation
Price to revenue (TTM)
5.464
Price to book
12.18
Price to tangible book (TTM)
12.72
Price to free cash flow (TTM)
-90.783
Free cash flow yield (TTM)
-1.10%
Free cash flow per share (TTM)
-0.048
Growth
Revenue change (TTM)
19.57%
Earnings per share change (TTM)
-61.82%
3-year revenue growth (CAGR)
13.32%
3-year earnings per share growth (CAGR)
-16.81%
What the Analysts think about KRMD
Analyst ratings (Buy, Hold, Sell) for Repro Med Systems stock.
KRMD Financial Performance
Revenues and expenses
KRMD Earnings Performance
Company profitability
KRMD News
AllArticlesVideos
KORU Medical Systems Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Business Wire·3 weeks ago
KORU Medical Systems to Participate in the Canaccord Genuity 45th Annual Growth Conference
Business Wire·4 weeks ago
KORU Medical Systems Appoints Adam Kalbermatten as Chief Commercial Officer
Business Wire·2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Repro Med Systems stock?
Repro Med Systems (KRMD) has a market cap of $203M as of August 25, 2025.
What is the P/E ratio for Repro Med Systems stock?
The price to earnings (P/E) ratio for Repro Med Systems (KRMD) stock is 0 as of August 25, 2025.
Does Repro Med Systems stock pay dividends?
No, Repro Med Systems (KRMD) stock does not pay dividends to its shareholders as of August 25, 2025.
When is the next Repro Med Systems dividend payment date?
Repro Med Systems (KRMD) stock does not pay dividends to its shareholders.
What is the beta indicator for Repro Med Systems?
Repro Med Systems (KRMD) has a beta rating of 0.47. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.